Proteomics

Dataset Information

0

A peptide-derived strategy for specifically targeting the mitochondrial-ER network of cancer cells: a new paradigm in fighting cancer


ABSTRACT: An effective anti-cancer therapy should exclusively target cancer cells and trigger in them a broad spectrum of cell death pathways that will prevent avoidance. Here, we present a novel paradigm in cancer therapy that specifically targets the mitochondria and ER of cancer cells. We developed a peptide derived from the flexible and transmembrane domains of the human protein NAF-1/CISD2. This peptide (NAF-1) specifically permeated through the plasma membranes of human epithelial breast cancer cells, abolished their mitochondrial-ER network, and triggered cell death with characteristics of apoptosis, ferroptosis and necroptosis. In vivo analysis revealed that the peptide significantly decreased tumor growth in mice carrying xenograft human tumors. Computational simulations of cancer vs. normal cells membranes revealed that the specificity of the peptide to cancer cells is due to its selective recognition of their membrane composition. NAF-1 represents therefore a promising anti-cancer lead compound that acts via a unique mechanism.

INSTRUMENT(S): timsTOF Pro

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Epithelial Cell, Cell Culture

DISEASE(S): Breast Cancer

SUBMITTER: Pei Liu  

LAB HEAD: Ron Mittler

PROVIDER: PXD030509 | Pride | 2022-08-12

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
20211217_110132_Mittler_DIA_MCF-MCA.sne Other
PTC-DIA-S1-halfuL_321.d.zip Other
PTC-DIA-S10_288.d.zip Other
PTC-DIA-S11_289.d.zip Other
PTC-DIA-S12_290.d.zip Other
Items per page:
1 - 5 of 44
altmetric image

Publications

A peptide-derived strategy for specifically targeting the mitochondria and ER of cancer cells: a new approach in fighting cancer.

Sohn Yang Sung YS   Losub-Amir Anat A   Cardenas Alfredo E AE   Karmi Ola O   Yahana Merav Darash MD   Gruman Tal T   Rowland Linda L   Marjault Henri-Baptiste HB   Webb Lauren J LJ   Mittler Ron R   Elber Ron R   Friedler Assaf A   Nechushtai Rachel R  

Chemical science 20220526 23


An effective anti-cancer therapy should exclusively target cancer cells and trigger in them a broad spectrum of cell death pathways that will prevent avoidance. Here, we present a new approach in cancer therapy that specifically targets the mitochondria and ER of cancer cells. We developed a peptide derived from the flexible and transmembrane domains of the human protein NAF-1/CISD2. This peptide (NAF-1<sup>44-67</sup>) specifically permeates through the plasma membranes of human epithelial brea  ...[more]

Similar Datasets

2024-08-13 | PXD054527 | Pride
2023-08-18 | PXD039343 | Pride
2022-08-12 | PXD034640 | Pride
2023-10-11 | PXD034357 | Pride
2023-10-24 | PXD040281 | Pride
2024-05-31 | PXD047793 | Pride
2023-03-10 | PXD037766 | Pride
2023-11-08 | PXD042367 | Pride
2024-08-22 | PXD043851 | Pride
2022-04-27 | PXD023904 | Pride